Common Contracts
2 similar Common Stock Purchase Warrant contracts by Recro Pharma, Inc.
RECRO PHARMA, INC. COMMON STOCK PURCHASE WARRANT dated as of November 17, 2017Common Stock Purchase Warrant • November 20th, 2017 • Recro Pharma, Inc. • Pharmaceutical preparations • Pennsylvania
THIS CERTIFIES THAT, for value received, Athyrium Opportunities II Acquisition LP or its successors or permitted assigns (such Person and such successors and assigns each being the “Warrant Holder” with respect to the Warrant held by it), at any time and from time to time on any Business Day on or prior to 5:00 p.m. (New York City time) on the Expiration Date (as herein defined), is entitled (a) to purchase from Recro Pharma, Inc., a Pennsylvania corporation (the “Company”), 174,332 Shares at a price per Share equal to the Exercise Price (as herein defined), and (b) to the other rights set forth herein; provided that the number of Shares issuable upon any exercise of this Warrant and the Exercise Price shall be adjusted and readjusted from time to time in accordance with Section 5. This Common Stock Purchase Warrant (this “Warrant”) is issued under and pursuant to that certain Credit Agreement, dated as of November 17, 2017, by and among the Company, as the borrower, the guarantors par
RECRO PHARMA, INC. COMMON STOCK PURCHASE WARRANT dated as of November 17, 2017Common Stock Purchase Warrant • November 20th, 2017 • Recro Pharma, Inc. • Pharmaceutical preparations • Pennsylvania
THIS CERTIFIES THAT, for value received, Athyrium Opportunities III Acquisition LP or its successors or permitted assigns (such Person and such successors and assigns each being the “Warrant Holder” with respect to the Warrant held by it), at any time and from time to time on any Business Day on or prior to 5:00 p.m. (New York City time) on the Expiration Date (as herein defined), is entitled (a) to purchase from Recro Pharma, Inc., a Pennsylvania corporation (the “Company”), 174,332 Shares at a price per Share equal to the Exercise Price (as herein defined), and (b) to the other rights set forth herein; provided that the number of Shares issuable upon any exercise of this Warrant and the Exercise Price shall be adjusted and readjusted from time to time in accordance with Section 5. This Common Stock Purchase Warrant (this “Warrant”) is issued under and pursuant to that certain Credit Agreement, dated as of November 17, 2017, by and among the Company, as the borrower, the guarantors pa
